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AIntrathecal transplantation of bone marrow stromal
cells attenuates blood-spinal cord barrier disruption
induced by spinal cord ischemia-reperfusion injury
in rabbits
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Wen-Fei Tan, MD, PhD,a Paul F. White, PhD, MD,b,c and Hong Ma, MD, PhD,a Shenyang, Liaoning,
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Objective: Intrathecal administration of bone marrow stromal cells has been found to produce beneﬁcial effects on
ischemia-reperfusion injury to the spinal cord. The blood-spinal cord barrier is critical to maintain spinal cord homeostasis
and neurologic function. However, the effects of bone marrow stromal cells on the blood-spinal cord barrier after spinal
cord ischemia-reperfusion injury are not well understood. This study investigated the effects and possible mechanisms of
bone marrow stromal cells on blood-spinal cord barrier disruption induced by spinal cord ischemia-reperfusion injury.
Methods: This was a prospective animal study conducted at the Central Laboratory of the First Afﬁliated Hospital, China
Medical University. The study used 81 Japanese white rabbits (weight, 1.8-2.6 kg). Spinal cord ischemia-reperfusion
injury was induced in rabbits by infrarenal aortic occlusion for 30 minutes. Two days before the injury was induced,
bone marrow stromal cells (1 3 108 in 0.2-mL phosphate-buffered saline) were transplanted by intrathecal injection.
Hind-limb motor function was assessed using Tarlov criteria, and motor neurons in the ventral gray matter were counted
by histologic examination. The permeability of the blood-spinal cord barrier was examined using Evans blue (EB) and
lanthanum nitrate as vascular tracers. The expression and localization of tight junction protein occludin were assessed by
Western blot, real-time polymerase chain reaction, and immunoﬂuorescence analysis. Matrix metalloproteinase-9
(MMP-9) and tumor necrosis factor-a (TNF-a) expression were also measured.
Results: Intrathecal transplantation of bone marrow stromal cells minimized the neuromotor dysfunction and histo-
pathologic deﬁcits (P < .01) and attenuated EB extravasation at 4 hours (5.41 ± 0.40 vs 7.94 ± 0.36 mg/g; P < .01)
and 24 hours (9.03 ± 0.44 vs 15.77 ± 0.89 mg/g; P < .01) after spinal cord ischemia-reperfusion injury. In addition,
bone marrow stromal cells treatment suppressed spinal cord ischemia-reperfusion injury-induced decreases in occludin
(P < .01). Finally, bone marrow stromal cells reduced the excessive expression of MMP-9 and TNF-a (P < .01).
Conclusions: Pre-emptive intrathecal transplantation of bone marrow stromal cells stabilized the blood-spinal cord barrier
integrity after spinal cord ischemia-reperfusion injury in a rabbit model of transient aortic occlusion. This beneﬁcial effect
was partly mediated by inhibition of MMP-9 and TNF-a and represents a potential therapeutic approach to mitigating
spinal cord injury after aortic occlusion. (J Vasc Surg 2013;58:1043-52.)
Clinical Relevance: Clinical thoracoabdominal aorta surgery may trigger spinal cord ischemia-reperfusion injury,
resulting in paraplegia as well as bladder, bowel, and sexual dysfunction. Transplantation of bone marrow stromal cells
has attracted increasing attention in the ﬁeld of nervous system protection, but its mechanisms have not been elucidated
completely. The blood-spinal cord barrier plays a crucial role to maintain normal spinal cord function. This study sug-
gested that intrathecal transplantation of bone marrow stromal cells stabilized blood-spinal cord barrier integrity through
inhibiting the upregulation of matrix metalloproteinase-9 and tumor necrosis factor-a and ameliorated spinal cord
ischemia-reperfusion injury. This may provide a novel train of thought to enhance the protective effects of bone marrow
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1044 Fang et al October 2013Spinal cord ischemia is a well-recognized complication
of acute aortic occlusion for resuscitation in the setting of
shock or for the purposes of elective or emergency aortic
reconstruction.1,2 Bone marrow stromal cells (also called
mesenchymal stem cells) comprise a heterogeneous popula-
tion of cells located in bone marrow. Bone marrow stromal
cells have been transplanted into the intrathecal space in an
attempt to maintain spinal cord function in the setting of an
acute contusion and hemisection injury, as well as injury
resulting from ischemia and reperfusion.3-6 Although not
well-characterized, the possible beneﬁcial effect of bone
marrow stromal cells may be related to differentiation,3
secretion of neurotrophic and antiapoptotic factors,7,8
and promotion of local neonatal angiogenic factors.6
In the setting of trauma, alteration in the blood-spinal
cord barrier allows a variety of harmful molecules and
proteins to enter the cord parenchyma from the blood
stream.9 Several neurochemicals have been implicated in
disruption of the blood-spinal cord barrier after cord injury,
among them matrix metalloproteinase-9 (MMP-9) and
tumor necrosis factor-a (TNF-a).10,11 These substances
alter cord microvascular permeability and result in cellular
ischemia, inﬂammation, and edema that worsen the initial
cord injury. In addition, breakdown of the blood-spinal
cord barrier appears to play an important role in regenera-
tion and repair of the spinal cord after trauma.12
The role of intrastriatal transplantation of bone marrow
stromal cells has been examined in the setting of cerebral
ischemia in rats.13 That study showed that bone marrow
stromal cells restored cerebral blood ﬂow, stabilized the
blood-brain barrier, and ultimately, improved the outcome
after stroke. However, little is known about the effects of
bone marrow stromal cells on the blood-spinal cord barrier
disruption after spinal cord ischemia. Occludin, a tight
junction (TJ) protein that maintains blood-brain barrier
and blood-spinal cord barrier integrity, has been reported
to be a sensitive indicator of the functional state of the
blood-brain barrier.14
The primary objective of this study was to investigate
potential protective effects of bone marrow stromal cells
on the blood-spinal cord barrier and occludin levels in
a rabbit model of ischemia reperfusion. Secondary objec-
tives were to evaluate the role of MMP-9 and TNF-a in
ischemia-induced blood-spinal cord barrier breakdown
with and without pretreatment with bone marrow stromal
cells.
METHODS
All experimental animal procedures were conducted
with the approval of the Ethics Committee of China
Medical University in accordance with Guide for the Care
and Use of Laboratory Animals (U.S. National Institutes
of Health publication No. 85-23, National Academy Press,
Washington DC, revised 1996).
Animals and surgical procedure. Japanese white
rabbits, weighing 1.8 to 2.6 kg, were used in the study.
The rabbits were anesthetized with intravenous 20% ethyl
carbamate (1 g/kg) and were allowed to breathespontaneously. Core body temperature was continuously
monitored with a rectal probe and was maintained at
38.5 6 0.5C with the aid of a heat lamp. Two catheters
were inserted into the ear and femoral artery to measure
proximal and distal blood pressure. Lidocaine (0.5%) was
administered at the site of the skin incision as a local anes-
thetic. The infrarenal abdominal aorta was exposed through
a transperitoneal approach. After systemic heparinization
(200 U/kg), spinal cord ischemia was induced by cross-
clamping the abdominal aorta just 1 cm distal to the left
renal artery. The clamp was released after 30 minutes.
Bone marrow stromal cells culture and intrathecal
injection. Bone marrow was harvested aseptically from
tibias of 2-month-old rabbits, and the nucleated cells
were isolated by density gradient centrifugation using
Percoll (1.073 g/mL; Sigma, St. Louis, Mo). The cells
were plated in growth medium consisting of Dulbecco
modiﬁed Eagle’s medium/F12 supplemented with 20%
fetal bovine serum and benzylpenicillin (1  105 U/mL).
Bone marrow stromal cells were easily isolated in the
medium because of their tendency to adhere to plastic.
After 3 days, the ﬂasks were washed twice with phosphate-
buffered saline (PBS) to remove nonadherent cells. The
remaining cells were fed every third day.
Cultures of bone marrow stromal cells were maintained
at 50% conﬂuence and were passaged three times. Accord-
ing to the detection of ﬂow cytometric plots, third-
generation cells are considered to be bone marrow stromal
cells. They expressed on their surface CD44 (hyaluronate
receptor), CD29 (b1 integrin), and lacked the expression
of CD45 and CD34, the phenotype of hemopoietic cells.15
The bone marrow stromal cells were harvested by trypsini-
zation and were resuspended in PBS before intrathecal
injection.
After anesthesia with ethyl carbamate, the interverte-
bral space between L5 and L6 was punctured with
a 16-gauge needle, and polyethylene-10 tubing was
inserted through it into the subarachnoid space. The
desired position of the catheter was conﬁrmed by cautious
aspiration of cerebrospinal ﬂuid. After intrathecal injection
of 1  108 bone marrow stromal cells in 0.2 mL total ﬂuid
volume PBS, or the same volume of PBS (for sham group),
the catheter was removed. The animals were placed head-
up for 60 minutes. The animals were included in the study
only if they had a normal hind-limb motor function just
before spinal cord ischemia-reperfusion injury was induced.
Experimental protocol. Rabbits were assigned to four
groups randomly by means of a random number table.
Group sham (n ¼ 15) was given an intrathecal injection
of PBS, and the abdominal aorta was exposed, but without
occlusion. Group sham þ bone marrow stromal cells
(BMSCs; n ¼ 12) received an intrathecal injection of
bone marrow stromal cells and the abdominal aorta was
exposed, without occlusion. Group ischemia-reperfusion
(IR; n ¼ 27) received intrathecal PBS and subsequently
underwent to 30 minutes of spinal cord ischemia. Group
IR þ BMSCs (n ¼ 27) received an intrathecal injection of
bone marrow stromal cells and underwent 30 minutes of
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cross-clamping for 30 minutes was performed 2 days after
the experimental intrathecal injection.
Neurologic assessment. At 4 and 24 hours after
injury, hind limb motor function was assessed by two
blinded observers using a modiﬁed Tarlov scale16-18: 0,
paraplegic with no evident lower extremity motor function;
1, poor lower extremity motor function, weak antigravity
movement only; 2, moderate lower extremity function with
good antigravity strength but inability to draw legs under
body; 3, excellent motor function with the ability to draw
legs under body and hop, but not normally; and 4, normal
motor function.
Histologic study. All animals were euthanized by
a lethal injection of pentobarbital (200 mg/kg) 24 hours
after ischemia-reperfusion injury, and the spinal cords
(L4-L6) were quickly removed. Parafﬁn-embedded sections
(4 mm) were stained with hematoxylin and eosin. In cases in
which the cytoplasm was diffusely eosinophilic, the large
motor neuron cells were considered to be necrotic or
dead. When the cells demonstrated basophilic stippling
(containing Nissl substance), the motor neuron cells were
considered to be viable or alive. The intact motor neurons in
the ventral gray matter were counted by a blinded investi-
gator in three sections for each rabbit, and the results were
averaged.
Measurement of Evans blue extravasation. Blood-
spinal cord barrier permeability was determined by
measuring Evans blue (EB) extravasation. After ischemia-
reperfusion injury, 2% EB dye (10 mL/kg; Sigma) was
slowly intravenously administered after ischemia-
reperfusion injury. After the EB circulated for 1 hour, the
rabbits were anesthetized and perfused through the
ascending aorta with 500 mL/kg saline, and the spinal
cords (L4-L6) were removed. EB content and EB ﬂuo-
rescence were the two methods used to measure EB
extravasation:
First, the spinal cord tissue was weighed and soaked in
methanamide for 24 hours (60C) and then centrifuged.
The absorption of the supernatant was measured at
632 nm with a microplate reader (BioTek, Winooski,
Vt). The content of EB was measured as micrograms per
gram of spinal cord tissue by standardized curve.
Second, the spinal cord tissue was ﬁxed in 4% parafor-
maldehyde and sectioned (10 mm) and kept frozen and
sealed in a light-tight container before measurement of
dye ﬂuorescence. EB staining was visualized using a BX-
60 (Olympus, Melville, NY) ﬂuorescence microscope
(green zone).
Transmission electron microscope study of blood-
spinal cord barrier permeability. At 24 hours after
ischemia-reperfusion injury, the rabbits were anesthetized
and perfused with 500 mL/kg saline rapidly through the
ascending aorta, followed with 500 mL/kg ﬁxative (4%
glutaraldehyde-2% lanthanum nitrate-0.1M sodium
cacodylate trihydrate) over 20 minutes. The spinal cords
(L4-L6) were removed and cut into 1-mm3 pieces. The
isolated tissues were immersed in the above ﬁxative for2 hours and then washed three times in 2% lanthanum
nitrate-0.1M sodium cacodylate trihydrate. The tissues
were immersed in 1% osmium tetroxide for 2 hours and
then washed with sodium cacodylate trihydrate. The
sections were dyed with acetic acid, uranium, and lead,
mounted on copper grids (200 meshes), and examined
under a JEM-1200 EX transmission electron microscope
(Joel, Tokyo, Japan). The integrity of the blood-spinal cord
barrier was assessed by lanthanum nitrate extravasation.
Immunoﬂuorescence staining of the TJ protein. To
identify the TJ protein occludin colocalized with vascular
endothelial cells, double immunoﬂuorescence labeling for
occludin with CD31 was performed. Each section was ﬁrst
treated with the primary mouse anti-CD31 (dilution 1:20;
Abcam, Cambridge, Mass) with donkey anti-mouse Alexa
Fluor 594 (dilution 1:500; Invitrogen, Carlsbad, Calif),
and was followed by mouse anti-occludin-ﬂuorescein
isothiocyanate conjugate (dilution 1:50; Invitrogen,
Camarillo, Calif) and analyzed by a Leica TCS SP2 (Leica
Microsystems, Bannockburn, Ill) laser scanning spectral
confocal microscope.
Western blot. The expression of occludin, MMP-9,
and TNF-a in spinal cord tissue was determined by
Western blot analyses performed as previously described.19
The antibodies used in this experiment were mouse
monoclonal antioccludin (Invitrogen), mouse monoclonal
anti-MMP-9 (Abcam), rabbit polyclonal anti-TNF-a
(Bioss, Beijing, China), and horseradish peroxidase-
conjugated secondary antibodies (Bioss). Semiquantitation
of scanned images was performed using Quantity One soft-
ware (Bio-Rad Laboratories, Milan, Italy).
Real-time PCR. Total RNA was extracted using
a TRIzol Kit and converted to ﬁrst-strand complemen-
tary DNA according to the manufacturer’s instructions.
Quantitative real-time polymerase chain reaction (PCR)
was performed using SYBR Green SuperMix-UDG in
a Prism 7000 Q real-time PCR detection system (Applied
Biosystems, Foster City, Calif). The primer sequences used
for PCR were:
Occludin (218 bp): forward 50-GCT TCT GGA TCT
ATG TAT GGC TCA C-30; reverse 50-TCA TAG CGG
TCC ATC TTT CTT CGA G-30
MMP-9 (119 bp): forward 50-TGT GTC TTC CCC
TTC GTC TT-30; reverse 50-CCC CAC TTC TTG TCG
CTG T-30
Glyceraldehyde-3-phosphate dehydrogenase (177 bp):
forward 50-TCG GCA TTG TGG AGG GGC TC-30;
reverse 50-TCC CGT TCA GCT CGG GGA G-30
Ampliﬁcation was performed by using the following
cycles: 50C for 2 minutes (uracil-DNA glycosylase incuba-
tion), 95C for 10 minutes, followed by 40 cycles of dena-
turing at 95C for 15 seconds and annealing at 60C for
30 seconds. All reactions were performed in triplicate.
Melting curve analysis was performed to ensure the speci-
ﬁcity of quantitative PCR. Data analysis was performed
using the 2-DDCT method described by Livak,20 where
glyceraldehyde-3-phosphate dehydrogenase was used as
reference gene.
Fig 1. Effects of bone marrow stromal cells (BMSCs) on neurologic motor function and histologic assessment of the
spinal cord after spinal cord ischemia-reperfusion (IR) injury. A, Tarlov score at 4 and 24 hours after injury (n ¼ 12).
B, Number of intact motor neurons in the ventral gray matter. **P < .01 vs group sham; ##P < .01 vs group IR. Data
are presented as mean 6 standard error (n ¼ 6). C, Representative sections of lumbar spinal cords stained with
hematoxylin and eosin (original magniﬁcation, 100).
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standard error. Statistical analyses were performed with
one-way analysis of variance with post hoc Bonferroni
test. P < .05 was considered to be statistically signiﬁcant.RESULTS
Neurologic assessment. All rabbits showed normal
hind limb motor function 2 days after intrathecal injection
before the induction of ischemia. The individual neurologic
scores of the four groups at 4 and 24 hours after reperfu-
sion are shown in Fig 1, A. The sham and sham þ
BMSCs animals retained a normal motor function of lower
limbs throughout the observation period. A 30-minute
period of infrarenal aortic occlusion resulted in severe
lower extremity neurologic deﬁcits in the control rabbits,
and prophylactic transplantation of bone marrow stromal
cells enhanced the recovery of motor function (group IR þ
BMSCs vs group IR; P < .01, at 4 and 24 hours
respectively).
Histologic assessment. A 30-minute ischemia resul-
ted in signiﬁcant loss of the motor neurons in the control
animals at 24 hours after the operation (P < .01 vs group
sham; Fig 1, B). In contrast, more intact motor neurons
were found in the lumbar spinal cords of group IR þ
BMSCs (P < .01 vs group IR; Fig 1, B). In group sham
and group sham þ BMSCs, the lumbar spinal cord was
intact, and more large motor neurons were present in the
anterior horn than in group IR (Fig 1, C).
Treatment with bone marrow stromal cells
decreases blood-spinal cord barrier leakage. The perme-
ability of the blood-spinal cord barrier was measured by EBextravasation, which was visualized as red ﬂuorescence
under the ﬂuorescent microscope. In sham rabbits, bone
marrow stromal cells had no effect on the blood-spinal
cord barrier. However, pre-emptive treatment with bone
marrow stromal cells signiﬁcantly decreased blood-spinal
cord barrier leakage after spinal cord ischemia-reperfusion
injury (Fig 2, A-F). Meanwhile, EB content was less at 4
and 24 hours in group IR þ BMSCs (5.41 6 0.40 and
9.03 6 0.44 mg/g) than in group IR (7.94 6 0.36 and
15.77 6 0.89 mg/g; P < .01; Fig 2, G).
As an electron-opaque tracer, lanthanum ion is widely
used to examine the integrity of the blood-brain barrier
by transmission electron microscope.19 As shown in
Fig 3, in sham spinal cord specimens, the lanthanum nitrate
was exclusively localized in the capillary. There was no
permeation of the lanthanum nitrate into the basement
membrane and beyond the microvessels. At 24 hours after
ischemia-reperfusion injury, a leakage of lanthanum nitrate
was found in the basement membrane, even invading into
the parenchyma along the TJ in group IR, whereas the
extravasation of lanthanum was reduced in group IR þ
BMSCs.
Treatment with bone marrow stromal cells sup-
pressed a decrease in occludin. Western blot analysis indi-
cated that the decrease in occludin after spinal cord
ischemia-reperfusion injury was inhibited by transplanted
bone marrow stromal cells (P < .01; Fig 4, A). Similarly,
real-time PCR showed bone marrow stromal cells increased
messenger RNA expression of occludin, which was reduced
by spinal cord ischemia-reperfusion injury (P < .01;
Fig 4, B). Double immunoﬂuorescence labeling for
occludin with vascular endothelial cells revealed that spinal
Fig 2. Effects of bone marrow stromal cells (BMSCs) on Evans blue (EB) extravasation after spinal cord ischemia-
reperfusion (IR) injury. Almost no red ﬂuorescence was seen in spinal cord parenchyma in (A) group sham and
(B) group sham þ BMSCs. C,Much red ﬂuorescence could be seen at 4 hours after injury. E, This turned stronger at
24 hours after injury, especially in gray matter. D and F, In contrast, EB red ﬂuorescence was signiﬁcantly weakened in
group IR þ BMSCs. G, Quantiﬁcation data of EB content of spinal cord (mg/g) are presented as mean 6 standard
error (n ¼ 6). **P < .01 vs group sham; ##P < .01 vs group IR.
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discontinuous arrangement of occludin-positive protein,
which can be ameliorated by pretreatment with bone
marrow stromal cells (Fig 4, C).
Treatment with bone marrow stromal cells inhibi-
ted upregulation of MMP-9. Western blot analysis indi-
cated that the level of MMP-9 increased after injury, and
transplantation of bone marrow stromal cells inhibited the
upregulation of MMP-9 (P < .01; Fig 5, A). Similarly, real-
time PCR showed bone marrow stromal cells decreased
messenger RNA expression of MMP-9, which was
increased by spinal cord ischemia-reperfusion injury (P <
.01; Fig 5, B).
Treatment with bone marrow stromal cells reduced
TNF-a expression. Western blot revealed that TNF-a was
expressed at very low levels in the sham group, was highlyexpressed after spinal cord ischemia-reperfusion injury, and
was reduced by transplantation of bone marrow stromal
cells (P < .01; Fig 5, C).DISCUSSION
The current investigation is among the ﬁrst to demon-
strate the effectiveness of bone marrow stromal cells in
reducing inﬂammation of the blood-spinal cord barrier
after ischemia-reperfusion injury. Findings from this study
show that bone marrow stromal cells administered in the
intrathecal space before ischemic injury reduce blood-
spinal cord barrier permeability as measured by EB and
lanthanum nitrate extravasation. Results from this work
also demonstrate that when administered in this pre-
emptive manner, bone marrow stromal cells preserve the
Fig 3. Effects of bone marrow stromal cells (BMSCs) on the ultrastructure of the blood-spinal cord barrier by
transmission electron microscopy at 24 hours after spinal cord ischemia-reperfusion (IR) injury. A, In group sham, the
lanthanum nitrate was exclusively localized in the capillary. B, In group IR, a leakage of lanthanum was found in the
basement membrane (BM), even invading into the parenchyma along the tight junction (TJ). C, In group IR þ
BMSCs, only little extravasation of lanthanum was observed. The unlabeled arrowheads indicate the leakage of
lanthanum. L, Capillary lumen. Scale bar: 1 mm.
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tion after ischemia-reperfusion injury to the spinal cord.
Compared with embryonic stem cells and neural stem
cells, bone marrow stromal cells can be readily harvested
and grown in cell culture. Moreover, autologous transplan-
tation of bone marrow stromal cells would circumvent
potential ethical and immune rejection considerations.
Bone marrow stromal cells may be candidates for treating
acute spinal cord ischemic injuries. In addition to their
multilineage differentiation potential and antiapoptotic
and immunomodulatory effects, bone marrow stromal cells
can also suppress inﬂammation.21 Inﬂammatory factors
play a critical role in disrupting the blood-spinal cord
barrier.
Three bone marrow stromal cell transplantation proto-
cols have been used in spinal cord injury. Previously, most
transplantations were carried out by direct local delivery of
cells into the spinal cord.3 However, this highly invasive
technique may cause additional damage and is difﬁcult to
translate to human patients. Another transplantation
protocol used the intravenous route, which is safe and
convenient, but a large number of cells are required. Intra-
thecal transplantation is a novel, minimally invasive method
that improves the efﬁciency of transplantation and
enhances the efﬁcacy of the treatment.22 Thus, intrathecal
injection of bone marrow stromal cells appears to be a suit-
able approach to study their effects of on the blood-spinal
cord barrier.
Shi et al6 examined the therapeutic effect of bone
marrow stromal cells on ischemia-injured spinal cord and
found that the therapeutic time window was crucial to
achieving therapeutic efﬁciency (earlier better than late).
They also conﬁrmed that prophylactic intrathecal trans-
plantation of bone marrow stromal cells played a potential
role in preventing neurologic injury after spinal cord
ischemia.5 Early neural damage and degeneration wasrelated to blood-brain barrier breakdown. Therefore, early
restoration of the barrier could alleviate neuropathologic
damage and facilitate recovery. Even better, prophylactic
treatment to maintain a healthy blood-brain barrier has
the potential to delay the neurodegeneration occurance.23
Jacobs et al24 reported severe vascular permeability disrup-
tion appeared as early as 30 minutes after spinal cord
ischemia-reperfusion in rabbits. To play the role of bone
marrow stromal cells against blood-spinal cord barrier
disruption as soon as possible, bone marrow stromal cells
were intrathecally transplanted 2 days before spinal cord
ischemia-reperfusion injury in the current study.
The current ﬁndings demonstrated that EB extravasa-
tion was increased at 24 hours after reperfusion; mean-
while, neurologic function and surviving motor neurons
decreased, compared with 4 hours, consistent with the
previous study.24 It demonstrates neurologic deterioration
after spinal cord ischemia-reperfusion injury is associated
with breakdown of blood-spinal cord barrier integrity.
Sharma et al25 suggest the capillaries are more numerous
in the spinal gray matter, where they form a dense capillary
bed, compared with the white matter. These ﬁndings are
consistent with the current observation that EB extravasa-
tion was greater in the gray matter.
The present study focused on the protective role of the
TJ protein occludin in attenuating the blood-spinal cord
barrier disruption. Occludin was the ﬁrst TJ transmem-
brane molecule discovered, and degradation of occludin
contributes to blood-brain barrier disruption in the early
stages of ischemic stroke.26 Moreover, early blood-brain
barrier permeability detected by quantitative magnetic
resonance imaging after ischemic stroke is related to occlu-
din phosphorylation.
In the current study, the permeability of the blood-
spinal cord barrier increased after spinal cord ischemia-
reperfusion injury concurrent with a decrease in occludin
Fig 4. Bone marrow stromal cell (BMSC) transplantation suppressed the decreases in the tight junction protein
occludin after spinal cord ischemia-reperfusion (IR) injury. A, Representative Western blot and quantitative protein
analysis of occludin in the spinal cord at 4 and 24 hours after injury. B, Real-time polymerase chain reaction analysis
shows occludin messenger RNA (mRNA) expression. The expression level of each sample is expressed as the ratio to
group sham. **P < .01 vs group sham; ##P < .01 vs group IR. Data are presented as mean 6 standard error (n ¼ 6).
C, Immunoﬂuorescence photomicrographs of occludin (green) along microvasculature (red) 24 hours after injury.
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cence intensity of occludin along the microvasculature also
appeared to be reduced after ischemia-reperfusion injury.
Furthermore, electron microscopy showed lanthanum was
present in basement membrane and invaded into the paren-
chyma along the TJ after ischemia-reperfusion injury. By
contrast, occludin expression was obviously increased in
rabbits treated with bone marrow stromal cells. This effect
was also clearly observed by immunoﬂuorescence, in which
continuity of occludin staining was markedly increased.
Meanwhile, lanthanum extravasation was considerably
attenuated.However, Noble and Wrathall27 and Sharma et al28
examined blood-spinal cord barrier leakage at the ultra-
structural level using horseradish peroxidase or lanthanum
as the tracer in spinal cord contusion and incision injuries,
respectively. These investigators reported that an increase
in endothelial cell membrane vesicular transport (rather
than widening of the TJ) was responsible for blood-spinal
cord barrier leakage. The different results may be due to
variation in the type of spinal cord insult and differences
in the experimental animal model. It is widely acknowl-
edged that blood-brain barrier disruption is related to
disruption of TJ in ischemic stroke animal models.25,29,30
Fig 5. Transplantation of bone marrow stromal cells (BMSCs) suppressed the upregulation of matrix metalloproteinase
(MMP)-9 and tumor necrosis factor (TNF)-a after spinal cord ischemia-reperfusion (IR) injury. A, Representative
Western blot and quantitative protein analysis of MMP-9 in spinal cord at 4 and 24 hours after injury. B, Real-time
polymerase chain reaction analysis of MMP-9 messenger RNA (mRNA) expression. C, Representative Western blot
and quantitative protein analysis of TNF-a in spinal cord at 4 and 24 hours after injury. The expression level of each
sample is expressed as the ratio to group sham. **P < .01 vs group sham; ##P < .01 vs group IR. Data are presented as
mean 6 standard error (n ¼ 6).
JOURNAL OF VASCULAR SURGERY
1050 Fang et al October 2013Analogous to cerebral ischemia-reperfusion injury, the
blood-spinal cord barrier destruction likely has a direct
correlation to disruption of TJ after spinal cord ischemia-
reperfusion injury, and bone marrow stromal cells pro-
tected the blood-spinal cord barrier by reducing the loss
of TJ protein.
Excessive MMPs, and in particular MMP-9, signiﬁ-
cantly destroy barrier integrity by digesting basement
membranes and TJ proteins of endothelial cells.31,32
Another series of experiments showed that MMPs were
upregulated and associated with blood-brain barrier or
blood-spinal cord barrier dysfunction after stroke33 and
spinal cord contusion.10 MMP inhibitors have been
conﬁrmed to decrease infarct volume34 and protect the
blood-brain barrier31 in a stroke model.Several lines of recent evidence support a role of TNF-a
in pathologic blood-brain barrier opening in many central
nervous system diseases such as focal cerebral ischemia,
cerebral trauma, and multiple sclerosis.35-37 TNF-a induces
downregulation of occludin expression to increase blood-
brain barrier permeability38 and is a trigger to induce
MMP-9 release from pericytes through mitogen-activated
protein kinases and phosphoinositide-3-kinase/Akt.39
It has been clariﬁed that bone marrow stromal cells
possessed anti-inﬂammatory properties and signiﬁcantly
decreased TNF-a expression in a lipopolysaccharide-
induced inﬂammation model.40 This study presented that
the permeability of the blood-spinal cord barrier increased,
and TJ protein decreased after spinal cord ischemia-
reperfusion injury concurrently with MMP-9 and TNF-
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marrow stromal cells inhibited the elevation of MMP-9,
TNF-a, and protected blood-spinal cord barrier and TJ
protein, suggesting bone marrow stromal cells may alle-
viate disruption of the blood-spinal cord barrier via
suppression of MMP-9 and TNF-a.
CONCLUSIONS
Pre-emptive transplantation of bone marrow stromal
cells stabilized the blood-spinal cord barrier integrity
against spinal cord ischemia-reperfusion injury in a rabbit
model of transient aortic occlusion. This beneﬁcial effect
is partly mediated by inhibition of MMP-9 and TNF-
a and represents a potentially novel mode of therapy to
reduce ischemia-induced damage to the spinal cord.
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